Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Optimal pathologic staging: defining stage II disease.

Carolyn C Compton1

  • 1Office of Biorepositories and Biospecimen Research, National Cancer Institute, Bethesda, MD 20892, USA. comptcar@mail.nih.gov

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|November 17, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Large-Scale Saliva-Based Clinical Surveillance Enables Real Time SARS-CoV-2 Outbreak Detection and Genomic Tracking (Arizona, 2020-2023).

Diagnostics (Basel, Switzerland)·2025
Same author

Preanalytics and Precision Pathology: Pathology Practices to Ensure Molecular Integrity of Cancer Patient Biospecimens for Precision Medicine.

Archives of pathology & laboratory medicine·2019
Same author

The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more "personalized" approach to cancer staging.

CA: a cancer journal for clinicians·2017
Same author

A Study of Thymidylate Synthase Expression as a Biomarker for Resectable Colon Cancer: Alliance (Cancer and Leukemia Group B) 9581 and 89803.

The oncologist·2016
Same author

The impact of stage, grade, and mucinous histology on the efficacy of systemic chemotherapy in adenocarcinomas of the appendix: Analysis of the National Cancer Data Base.

Cancer·2015
Same author

A Novel Approach to High-Quality Postmortem Tissue Procurement: The GTEx Project.

Biopreservation and biobanking·2015

Accurate pathologic assessment of stage II colorectal cancer is crucial for identifying patients needing more than surgery. Key factors include lymph node analysis, tumor penetration, and resection margins for guiding adjuvant therapy decisions.

Area of Science:

  • Oncology
  • Pathology
  • Surgical Oncology

Background:

  • Tumor stage is the primary prognostic factor in colorectal cancer, guiding patient management.
  • Accurate pathologic assessment of stage II disease is critical for identifying patients who may require adjuvant therapy beyond surgery.
  • Key pathologic features include lymph node status, tumor invasion depth, and resection margins.

Purpose of the Study:

  • To highlight the critical role of pathologic assessment in stage II colorectal cancer.
  • To emphasize the importance of lymph node evaluation, tumor penetration, and resection margins.
  • To discuss adverse prognostic factors that may indicate the need for adjuvant therapies.

Main Methods:

  • Review of pathologic assessment criteria for stage II colorectal cancer.

Related Experiment Videos

  • Analysis of the significance of lymph node harvest adequacy and number for pN0 assignment.
  • Evaluation of prognostic value of lymphovascular invasion, venous invasion, and margin status.

    • Main Results:

    • Adequate surgical resection and thorough lymph node harvest are essential for accurate pN0 staging.
    • A minimum of 12-18 lymph nodes is recommended for pN0 assignment, with higher numbers increasing confidence.
    • Tumor involvement of lymphovascular channels, venous vessels, high grade, and positive margins are adverse prognostic indicators.

    Conclusions:

    • Pathologic assessment of stage II colorectal cancer is vital for prognosis and treatment decisions.
    • Thorough lymph node examination and evaluation of specific adverse features are crucial for identifying patients benefiting from adjuvant therapy.
    • The prognostic significance of isolated tumor cells requires further investigation.